Overview

Efficacy and the Tolerability of the Sequential Application of Two Marketed Products in Patients With Acne Vulgaris

Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The aim of this proof of principle study is to evaluate efficacy and safety of the sequential application of two marketed products for the treatment of acne vulgaris, using the Split-Face model
Phase:
Phase 2
Details
Lead Sponsor:
LEO Pharma